PEAK6 Investments’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,400
Closed -$119K 4333
2022
Q4
$119K Buy
+10,400
New +$154K ﹤0.01% 3572
2022
Q2
Sell
-6,700
Closed -$248K 6130
2022
Q1
$248K Sell
6,700
-20,700
-76% -$807K ﹤0.01% 3715
2021
Q4
$1.25M Sell
27,400
-76,000
-74% -$3.97M ﹤0.01% 2363
2021
Q3
$6.55M Sell
103,400
-171,000
-62% -$13M 0.01% 967
2021
Q2
$25.1M Sell
274,400
-45,100
-14% -$3.58M 0.06% 295
2021
Q1
$21.8M Buy
319,500
+146,100
+84% +$11.3M 0.05% 322
2020
Q4
$12.6M Buy
+173,400
New +$10M 0.03% 568
2020
Q3
Sell
-3,000
Closed -$106K 4411
2020
Q2
$106K Hold
3,000
﹤0.01% 3774
2020
Q1
$65K Buy
+3,000
New +$67.2K ﹤0.01% 3501
2019
Q2
Sell
-14,100
Closed -$444K 3713
2019
Q1
$444K Buy
+14,100
New +$411K ﹤0.01% 2462

Other funds holding CDNA

PEAK6 Investments's CDNA Position: Q1 2023 in Review

PEAK6 Investments sold out of CareDx (CDNA) in Q1 2023, closing a stake of 6,276 shares — an estimated $80.3K sold.

PEAK6 Investments first reported a position in CDNA in Q3 2018 and held it in 8 quarters. The position peaked at $2.42M in Q4 2021. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • PEAK6 Investments reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • PEAK6 Investments sold 6,276 CareDx shares in Q1 2023, an estimated $80.3K.
  • PEAK6 Investments first reported a position in CareDx in Q3 2018 and held it in 8 quarters.
  • PEAK6 Investments's CareDx position peaked at $2.42M in Q4 2021.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on PEAK6 Investments's 13F filing for Q1 2023, filed 12 May 2023.